We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$503M
AUM Growth
-$85.2M
Cap. Flow
-$69.1M
Cap. Flow %
-13.73%
Top 10 Hldgs %
34.85%
Holding
49
New
4
Increased
2
Reduced
37
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$18.1M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$14M
3
KMI icon
Kinder Morgan
KMI
+$10.3M
4
BNY
Bank of New York Mellon
BNY
+$740K
5
BMY icon
Bristol-Myers Squibb
BMY
+$51.5K

Top Sells

Rank Stock Value
1
KHC icon
Kraft Heinz
KHC
+$17.5M
2
AMGN icon
Amgen
AMGN
+$12.2M
3
XOM icon
ExxonMobil
XOM
+$12.1M
4
LOW icon
Lowe's Companies
LOW
+$4.26M
5
APTV icon
Aptiv
APTV
+$3.78M

Sector Composition

Rank Sector Weight
1 Healthcare 30.01%
2 Technology 13.31%
3 Consumer Discretionary 10.44%
4 Communication Services 9.33%
5 Financials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADBE icon
1
Adobe
ADBE
$103B
$18.3M 3.63%
84,515
-15,270
-15% -$3.1M
DHR icon
2
Danaher
DHR
$145B
$18.3M 3.63%
210,355
-29,001
-12% -$2.54M
SBUX icon
3
Starbucks
SBUX
$124B
$17.9M 3.56%
309,855
-39,060
-11% -$2.26M
MDLZ icon
4
Mondelez International
MDLZ
$79.4B
$17.6M 3.49%
421,255
-60,555
-13% -$2.63M
APTV icon
5
Aptiv
APTV
$10.1B
$17.4M 3.46%
205,055
-41,595
-17% -$3.78M
V icon
6
Visa
V
$671B
$17.4M 3.46%
145,640
-29,800
-17% -$3.61M
ICE icon
7
Intercontinental Exchange
ICE
$85B
$17.3M 3.43%
238,020
-49,010
-17% -$3.58M
LOW icon
8
Lowe's Companies
LOW
$121B
$17.2M 3.42%
196,290
-45,020
-19% -$4.26M
MSFT icon
9
Microsoft
MSFT
$3.66T
$17.1M 3.4%
187,542
-26,230
-12% -$2.4M
UNH icon
10
UnitedHealth
UNH
$364B
$17M 3.37%
79,210
-14,690
-16% -$3.36M
T icon
11
AT&T
T
$166B
$16.6M 3.3%
616,758
-100,531
-14% -$2.8M
FDX icon
12
FedEx
FDX
$77.3B
$16.3M 3.23%
67,695
-13,330
-16% -$3.37M
DD icon
13
DuPont de Nemours
DD
$19.5B
$16.2M 3.22%
100,586
-9,900
-9% -$1.79M
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.2T
$15.9M 3.17%
307,300
-40,400
-12% -$2.24M
PFE icon
15
Pfizer
PFE
$150B
$15.8M 3.13%
467,776
-62,175
-12% -$2.14M
ABBV icon
16
AbbVie
ABBV
$440B
$15.6M 3.09%
+164,415
New +$18.1M
ORCL icon
17
Oracle
ORCL
$442B
$15.2M 3.02%
332,000
-45,965
-12% -$2.29M
MRK icon
18
Merck
MRK
$328B
$15.2M 3.02%
292,103
-39,153
-12% -$2.11M
DUK icon
19
Duke Energy
DUK
$96.3B
$15M 2.97%
193,130
-14,580
-7% -$1.13M
PPL
20
PPL Corp
PPL
$26.7B
$14.5M 2.88%
512,580
-9,360
-2% -$279K
META icon
21
Meta Platforms (Facebook)
META
$1.47T
$14.4M 2.86%
90,160
-15,065
-14% -$2.7M
AVGO icon
22
Broadcom
AVGO
$1.98T
$14M 2.78%
593,400
-81,800
-12% -$2.06M
ABT icon
23
Abbott
ABT
$192B
$13.9M 2.77%
232,785
-40,910
-15% -$2.47M
D icon
24
Dominion Energy
D
$59.8B
$13.6M 2.7%
201,665
-19,940
-9% -$1.47M
TMO icon
25
Thermo Fisher Scientific
TMO
$223B
$13.6M 2.7%
65,810
-7,680
-10% -$1.61M
1
2

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q1 2018 Portfolio in Review

As of Q1 2018, Stralem & Co held 49 positions worth $503M, down 14% from $589M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Stralem & Co withdrew a net $69.1M in Q1 2018, closing 3 positions and reducing 37 holdings. Its most notable exit was Kraft Heinz, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Stralem & Co opened a new position in AbbVie worth $15.6M.

  • Stralem & Co's largest Q1 2018 buy was AbbVie: 164,415 shares worth $15.6M.
  • Stralem & Co added most to Bristol-Myers Squibb in Q1 2018, an estimated $51.5K increase.
  • Stralem & Co's biggest Q1 2018 reduction was Lowe's Companies, cutting an estimated $4.26M.
  • Stralem & Co fully exited Kraft Heinz in Q1 2018, selling an estimated $17.5M.
  • Stralem & Co's ten largest holdings make up 35% of its $503M portfolio in Q1 2018.
  • Stralem & Co opened 4 new positions and closed 3 in Q1 2018.
  • Stralem & Co's portfolio value fell 14% quarter-over-quarter to $503M.

Based on Stralem & Co's 13F filing for Q1 2018, filed 19 Apr 2018.